Locate providers:   



U.S. Food and Drug Administration has given approval to market Juvederm VOLUMA XC

Juvederm VOLUMA XC is the first and only facial filler approved by the FDA to temporarily correct age-related volume loss in the cheek area. According to Allergan, VOLUMA results can last upto 2 years and create a more youthful appearance to the face.

FDA Approves Voluma facial filler
This approval has been anticipated in the US by many dermatologists and cosmetic surgeons. There are many reasons why VOLUMA will be popular in the US. As our large baby boomer population ages, they lose facial fat in their cheeks, their faces tend to deflate and their skin sags. However, this generation tends to be less accepting of those trends.

"Proven to provide greater volume that lasts longer than other injectables on the market, VOLUMA acts as an imaginary 'tent pole' under the skin ? pushing up the skin and holding this effect in-place," describes Dr. Bruce Katz, Director of The JUVA Skin & Laser Center, New York's premier destination for the most advanced skin and laser treatments. "Because VOLUMA was developed to be smoother than other hyaluronic acid facial volumizers, it is easier to inject during treatment which results in a smooth, natural look and feel."

In a clinical study conducted by Allergan, 102 patients with facial volume loss each received one treatment of VOLUMA dermal filler. 6 to 18 months after the treatment, an assessment found almost 65% of patients' facial volume was rated as being 'very much improved'. And, more than 7 out of 10 patients described their facial volume as being 'very good' during 6 to 18 months following the treatment. In addition, VOLUMA is associated with having lower incidences of adverse events and allergic reactions than other facial volumizers.